Research carried out by the group of Myocardial Dysfunction and Heart Transplantation Institute of Health Research of Hospital Universitario La Fe, Valencia (IIS-La Fe), directed by Miguel Rivera, in collaboration with Puerta de Hierro Madrid Hospital and Clínico Universitario de Santiago de Compostela and the company Sistemas Genómicos, could serve as a basis for future gene therapy applied to modulate the impaired muscle contraction in patients with dilated cardiomyopathy.

Más información